RANDOMIZED TRIAL OF LOW-DOSE VERSUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE INDUCTION TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

被引：77
|
作者：
CAVALLI, F
GOLDHIRSCH, A
JUNGI, F
MARTZ, G
MERMILLOD, B
ALBERTO, P
机构：
[1] INSELSPITAL,INST MED ONCOL,CH-3010 BERN,SWITZERLAND
[2] INSELSPITAL,LUDWIG INST CANC RES,CH-3010 BERN,SWITZERLAND
[3] KANTONSSPITAL,MED KLIN C,DIV ONCOL,CH-9006 ST GALLEN,SWITZERLAND
[4] UNIV HOSP ZURICH,DIV ONCOL,CH-8091 ZURICH,SWITZERLAND
[5] HOP CANTONAL,SWISS GRP CLIN CANC RES,STAT OFF,CH-1211 GENEVA 4,SWITZERLAND
[6] HOP CANTONAL,DIV ONCOL,CH-1211 GENEVA 4,SWITZERLAND
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 05期
关键词：
D O I：
10.1200/JCO.1984.2.5.414
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：414 / 419
页数：6
相关论文
共 50 条
  • [21] SEQUENTIAL COMBINATION OF TAMOXIFEN AND HIGH-DOSE MEDROXYPROGESTERONE ACETATE - THERAPEUTIC AND ENDOCRINE EFFECTS IN POSTMENOPAUSAL ADVANCED BREAST-CANCER PATIENTS
    GASPARINI, G
    CANOBBIO, L
    GALLIGIONI, E
    FASSIO, T
    BREMA, F
    CRIVELLARI, D
    VILLALTA, D
    DIFRONZO, G
    TALAMINI, R
    MONFARDINI, S
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (10): : 1451 - 1459
  • [22] TREATMENT OF POSTMENOPAUSAL ADVANCED BREAST-CANCER WITH LOW-DOSE AMINOGLUTETHIMIDE
    HOFFKEN, K
    MILLER, AA
    MILLER, B
    HOFFMANN, B
    BECHER, R
    AULBERT, E
    SCHOETENSACK, B
    SCHIMMEL, G
    SCHILCHER, RB
    CALLIES, R
    SCHMIDT, CG
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (06): : 736 - 736
  • [23] HIGH-DOSE MEGESTROL-ACETATE IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER
    TCHEKMEDYIAN, NS
    TAIT, N
    AISNER, J
    SEMINARS IN ONCOLOGY, 1986, 13 (04) : 20 - 25
  • [24] A RANDOMIZED TRIAL OF MITOMYCIN-C (M) VERSUS MITOMYCIN-C PLUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MMPA) IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, G
    FALKSON, CB
    FALKSON, HC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (01): : 14 - 17
  • [25] ADRENAL SUPPRESSION BY ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER PATIENTS
    VANVEELEN, H
    WILLEMSE, PHB
    SLEIJFER, DT
    PRATT, JJ
    SLUITER, WJ
    DOORENBOS, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 12 (02) : 83 - 86
  • [26] MECHANISM OF ADRENAL SUPPRESSION BY HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER PATIENTS
    VANVEELEN, H
    WILLEMSE, PHB
    SLEIJFER, DT
    VANDERPLOEG, E
    SLUITER, WJ
    DOORENBOS, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (02) : 167 - 170
  • [27] AN EVALUATION OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) THERAPY IN WOMEN WITH ADVANCED BREAST-CANCER
    JOHNSON, JR
    PRIESTMAN, TJ
    FOTHERBY, K
    KELLY, KA
    PRIESTMAN, SG
    BRITISH JOURNAL OF CANCER, 1984, 50 (03) : 363 - 366
  • [28] A PROSPECTIVE RANDOMIZED TRIAL TO COMPARE THE EFFICACY AND TOLERABILITY OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) AND AMINOGLUTETHIMIDE (AG) IN ADVANCED BREAST-CANCER
    CANNEY, PA
    PRIESTMAN, TJ
    LATIEF, TN
    SPOONER, D
    ANTICANCER RESEARCH, 1986, 6 (03) : 391 - 391
  • [29] A PHASE-II STUDY OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    FALKSON, G
    FALKSON, HC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 11 (01) : 16 - 18
  • [30] LOW-DOSE AMINOGLUTETHIMIDE FOR ADVANCED POSTMENOPAUSAL BREAST-CANCER
    CANTWELL, BMJ
    SAINSBURY, R
    HARRIS, AL
    WILSON, RG
    FARNDON, J
    DAWES, P
    EVANS, RGB
    DOWSETT, M
    BRITISH JOURNAL OF CANCER, 1984, 50 (02) : 252 - 252
12345